| Fair Value and Related Number of Derivative Contracts Categorized by Type of Derivative Contract |
The following tables present the fair value and related number of derivative contracts at May 31, 2016 and November 30, 2015 categorized by type of derivative contract and the platform on which these derivatives are transacted. The fair value of assets/liabilities represents our receivable/payable for derivative financial instruments, gross of counterparty netting and cash collateral received and pledged. The following tables also provide information regarding 1) the extent to which, under enforceable master netting arrangements, such balances are presented net in the Consolidated Statements of Financial Condition as appropriate under U.S. GAAP and 2) the extent to which other rights of setoff associated with these arrangements exist and could have an effect on our financial position (in thousands, except contract amounts). | | | | | | | | | | | | | | | | May 31, 2016 (1) | | Assets | | Liabilities | | Fair Value | | Number of Contracts | | Fair Value | | Number of Contracts | Interest rate contracts: | | | | | | | | Exchange-traded | $ | 3,602 |
| | 71,389 |
| | $ | 1,313 |
| | 94,606 |
| Cleared OTC | 3,317,398 |
| | 3,220 |
| | 3,317,602 |
| | 3,135 |
| Bilateral OTC | 690,520 |
| | 2,100 |
| | 645,030 |
| | 1,145 |
| Foreign exchange contracts: | | | | | | | | Exchange-traded | — |
| | 240 |
| | — |
| | 161 |
| Bilateral OTC | 398,620 |
| | 8,291 |
| | 417,400 |
| | 7,765 |
| Equity contracts: | | | | | | | | Exchange-traded | 807,139 |
| | 3,239,347 |
| | 1,012,583 |
| | 2,782,492 |
| Bilateral OTC | 96,354 |
| | 1,003 |
| | 70,335 |
| | 1,070 |
| Commodity contracts: | | | | | | | | Exchange-traded | — |
| | 1,548 |
| | — |
| | 931 |
| Bilateral OTC | 7,258 |
| | 1 |
| | 335 |
| | 2 |
| Credit contracts: | | | | | | | | Cleared OTC | 4,488 |
| | 10 |
| | 7,219 |
| | 12 |
| Bilateral OTC | 16,930 |
| | 82 |
| | 37,268 |
| | 95 |
| Total gross derivative assets/ liabilities: | | | | | | | | Exchange-traded | 810,741 |
| |
| | 1,013,896 |
| |
| Cleared OTC | 3,321,886 |
| |
| | 3,324,821 |
| |
| Bilateral OTC | 1,209,682 |
| |
| | 1,170,368 |
| |
| Amounts offset in the Consolidated Statements of Financial Condition (2): | | | | | | | | Exchange-traded | (760,612 | ) | | | | (760,612 | ) | | | Cleared OTC | (3,301,710 | ) | | | | (3,301,710 | ) | | | Bilateral OTC | (968,565 | ) | | | | (1,055,892 | ) | | | Net amounts per Consolidated Statements of Financial Condition (3) | $ | 311,422 |
|
|
|
|
| $ | 390,871 |
| | |
| | (1) | Exchange traded derivatives include derivatives executed on an organized exchange. Cleared OTC derivatives include derivatives executed bilaterally and subsequently novated to and cleared through central clearing counterparties. Bilateral OTC derivatives include derivatives executed and settled bilaterally without the use of an organized exchange or central clearing counterparty. |
| | (2) | Amounts netted include both netting by counterparty and for cash collateral paid or received. |
| | (3) | We have not received or pledged additional collateral under master netting agreements and/or other credit support agreements that is eligible to be offset beyond what has been offset in the Consolidated Statements of Financial Condition. |
| | | | | | | | | | | | | | | | November 30, 2015 (1) | | Assets | | Liabilities | | Fair Value | | Number of Contracts | | Fair Value | | Number of Contracts | Interest rate contracts: | | | | | | | | Exchange-traded | $ | 998 |
| | 52,605 |
| | $ | 364 |
| | 70,672 |
| Cleared OTC | 2,213,730 |
| | 2,742 |
| | 2,202,836 |
| | 2,869 |
| Bilateral OTC | 695,365 |
| | 1,401 |
| | 646,758 |
| | 1,363 |
| Foreign exchange contracts: | | | | | | | | Exchange-traded | — |
| | 441 |
| | — |
| | 112 |
| Bilateral OTC (4) | 453,202 |
| | 7,646 |
| | 466,021 |
| | 7,264 |
| Equity contracts: | | | | | | | | Exchange-traded | 955,287 |
| | 3,054,315 |
| | 1,004,699 |
| | 2,943,657 |
| Bilateral OTC | 61,004 |
| | 1,039 |
| | 81,085 |
| | 1,070 |
| Commodity contracts: | | | | | | | | Exchange-traded | — |
| | 1,726 |
| | — |
| | 1,684 |
| Bilateral OTC (4) | 19,342 |
| | 29 |
| | 4,628 |
| | 28 |
| Credit contracts: | | | | | | | | Cleared OTC | 621 |
| | 39 |
| | 841 |
| | 44 |
| Bilateral OTC | 16,977 |
| | 100 |
| | 59,314 |
| | 135 |
| Total gross derivative assets/liabilities: | | | | | | | | Exchange-traded | 956,285 |
| | | | 1,005,063 |
| | | Cleared OTC | 2,214,351 |
| | | | 2,203,677 |
| | | Bilateral OTC | 1,245,890 |
| | | | 1,257,806 |
| | | Amounts offset in the Consolidated Statements of Financial Condition (2): | | | | | | | | Exchange-traded | (938,482 | ) | | | | (938,482 | ) | | | Cleared OTC | (2,184,438 | ) | | | | (2,184,438 | ) | | | Bilateral OTC | (1,042,526 | ) | | | | (1,135,078 | ) | | | Net amounts per Consolidated Statements of Financial Condition (3) | $ | 251,080 |
| | | | $ | 208,548 |
| | |
| | (1) | Exchange traded derivatives include derivatives executed on an organized exchange. Cleared OTC derivatives include derivatives executed bilaterally and subsequently novated to and cleared through central clearing counterparties. Bilateral OTC derivatives include derivatives executed and settled bilaterally without the use of an organized exchange or central clearing counterparty. |
| | (2) | Amounts netted include both netting by counterparty and for cash collateral paid or received. |
| | (3) | We have not received or pledged additional collateral under master netting agreements and/or other credit support agreements that is eligible to be offset beyond what has been offset in the Consolidated Statements of Financial Condition. |
| | (4) | Bilateral OTC commodity contracts increased in assets by a fair value of $19.3 million and by 29 contracts and in liabilities by a fair value of $4.6 million and by 28 contracts with corresponding decreases in bilateral OTC foreign exchange contracts from those amounts previously reported to correct for the classification of certain contracts. The total amount of bilateral OTC contracts remained unchanged. |
|
| Unrealized and Realized Gains (Losses) on Derivative Contracts |
The following table presents unrealized and realized gains (losses) on derivative contracts: | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | Gains (Losses) | May 31, 2016 | | May 31, 2015 | | May 31, 2016 | | May 31, 2015 | Interest rate contracts | $ | (7,559 | ) | | $ | 18,064 |
| | $ | (80,084 | ) | | $ | (24,728 | ) | Foreign exchange contracts | 4,525 |
| | 8,352 |
| | 6,114 |
| | 23,524 |
| Equity contracts | (98,546 | ) | | (111,682 | ) | | (324,212 | ) | | (40,641 | ) | Commodity contracts | (315 | ) | | 5,746 |
| | (2,190 | ) | | 20,237 |
| Credit contracts | 10,306 |
| | 9,805 |
| | (2,583 | ) | | 3,763 |
| Total | $ | (91,589 | ) | | $ | (69,715 | ) | | $ | (402,955 | ) | | $ | (17,845 | ) |
|
| Remaining Contract Maturity of Fair Value of OTC Derivative Assets and Liabilities |
The following tables set forth by remaining contract maturity the fair value of OTC derivative assets and liabilities at May 31, 2016 (in thousands): | | | | | | | | | | | | | | | | | | | | | | OTC Derivative Assets (1) (2) (3) | | 0 – 12 Months | | 1 – 5 Years | | Greater Than 5 Years | | Cross-Maturity Netting (4) | | Total | Commodity swaps, options and forwards | $ | — |
| | $ | 7,258 |
| | $ | — |
| | $ | — |
| | $ | 7,258 |
| Equity swaps and options | 33,631 |
| | 2,646 |
| | — |
| | — |
| | 36,277 |
| Credit default swaps | — |
| | 6,362 |
| | 1,009 |
| | (1,194 | ) | | 6,177 |
| Total return swaps | 22,128 |
| | 5,101 |
| | — |
| | (635 | ) | | 26,594 |
| Foreign currency forwards, swaps and options | 86,663 |
| | 12,391 |
| | — |
| | (5,083 | ) | | 93,971 |
| Interest rate swaps, options and forwards | 55,585 |
| | 215,033 |
| | 59,686 |
| | (101,651 | ) | | 228,653 |
| Total | $ | 198,007 |
| | $ | 248,791 |
| | $ | 60,695 |
| | $ | (108,563 | ) | | 398,930 |
| Cross product counterparty netting | | | | | | | | | (1,148 | ) | Total OTC derivative assets included in Financial instruments owned | | | | | | | | | $ | 397,782 |
|
| | (1) | At May 31, 2016, we held exchange traded derivative assets and other credit agreements with a fair value of $53.2 million, which are not included in this table. |
| | (2) | OTC derivative assets in the table above are gross of collateral received. OTC derivative assets are recorded net of collateral received on the Consolidated Statements of Financial Condition. At May 31, 2016, cash collateral received was $139.5 million. |
| | (3) | Derivative fair values include counterparty netting within product category. |
| | (4) | Amounts represent the netting of receivable balances with payable balances for the same counterparty within product category across maturity categories. |
| | | | | | | | | | | | | | | | | | | | | | OTC Derivative Liabilities (1) (2) (3) | | 0 – 12 Months | | 1 – 5 Years | | Greater Than 5 Years | | Cross-Maturity Netting (4) | | Total | Equity swaps and options | $ | 3,957 |
| | $ | 18,813 |
| | $ | — |
| | $ | — |
| | $ | 22,770 |
| Credit default swaps | — |
| | 2,851 |
| | 11,461 |
| | (1,194 | ) | | 13,118 |
| Total return swaps | 8,721 |
| | 2,738 |
| | — |
| | (635 | ) | | 10,824 |
| Foreign currency forwards, swaps and options | 109,643 |
| | 8,191 |
| | — |
| | (5,083 | ) | | 112,751 |
| Fixed income forwards | 2,053 |
| | 1,207 |
| | — |
| | — |
| | 3,260 |
| Interest rate swaps, options and forwards | 33,749 |
| | 100,594 |
| | 153,026 |
| | (101,651 | ) | | 185,718 |
| Total | $ | 158,123 |
| | $ | 134,394 |
| | $ | 164,487 |
| | $ | (108,563 | ) | | 348,441 |
| Cross product counterparty netting | | | | | | | | | (1,148 | ) | Total OTC derivative liabilities included in Financial instruments sold, not yet purchased | | | | | | | | | $ | 347,293 |
|
| | (1) | At May 31, 2016, we held exchange traded derivative liabilities and other credit agreements with a fair value of $270.4 million, which are not included in this table. |
| | (2) | OTC derivative liabilities in the table above are gross of collateral pledged. OTC derivative liabilities are recorded net of collateral pledged on the Consolidated Statements of Financial Condition. At May 31, 2016, cash collateral pledged was $226.8 million. |
| | (3) | Derivative fair values include counterparty netting within product category. |
| | (4) | Amounts represent the netting of receivable balances with payable balances for the same counterparty within product category across maturity categories. |
|